Blood Plasma Market

Category : Healthcare & Life Sciences Reports | Delivery Format : PDF,PPT | Publisher: Reports and Insights | Pages : 200

To learn more about this report, request a free sample copy

Blood Plasma Market Overview

The report is titled ‘Blood Plasma Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the blood plasma market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. The blood plasma market is expected to grow at significant rate in the near future.

The global blood plasma market in 2020 is estimated for more than US$ 21.1 Bn and expected to reach at a value of US$ 35.4 Bn by 2028 with a significant CAGR of 6.7%.

Blood Plasma Introduction

The liquid portion of the blood is basically known as plasma that regulates the body temperature and blood pressure. The major purpose of the plasma is that it acts as a model for the transfer of proteins, nutrients, and hormones to the other body parts. The plasma consists of more than a hundred crucial proteins such as clotting factor, immunoglobulin, fibrinogen, and protease inhibitors.

Plasma is considered as a substance and protein and is utilized as a major component in clinical products to substitute the body fluids, antibodies, and clotting factors. The procedure of medical care for autoimmune disorders and hemophilia includes plasma as an essential element.

The soaring prevalence of several chronic and life-threatening diseases among the population is majorly driving the growth of the global blood plasma market across the globe.

Blood Plasma Market Dynamics

A huge upsurge in the count of patients suffering from hemophilia across the world is one of the major drivers that is estimated to propel the growth of the blood plasma market as there is increased use of plasma for the treatment of hemophilia.

By the same token, the sluggish lifestyle of the population comprising unhealthy diets and no physical activity coupled with the growing geriatric population is also adding to the rising life-threatening ailments across the world, further boosting the demand for blood plasma in the market.

Therefore, the global blood plasma market is projected to witness rapid growth in the forthcoming years. Along with that, an advance in the knowledge and awareness among the population with respect to blood plasma derivatives and donation of blood and plasma donation is also expected to give a breakthrough to the growth of the blood plasma market during the forecast timeframe.

In addition to that, the evolution in the healthcare industry and surging technological advancements in the diagnostics and treatment provided to patients has resulted in the development of plasma-derived therapeutic protein drugs, thereby augmenting the demand of blood plasma in the market.

Hence, the blood plasma market is expected to grow substantially in the coming years. However, the inadequate understanding and awareness about blood plasma in a few emerging regions along with its high cost may hold back the growth of the blood plasma market in the near future.

Blood Plasma Market Segmentation

The blood plasma market is segmented on the basis of blood plasma types, applications, end-user, and regions.

On Basis of Blood Plasma Types

•    Immunoglobulin

o    Intravenous Immunoglobulin

o    Subcutaneous Immunoglobulin

o    Other Immunoglobulin Type

•    Albumin

•    Hyperimmune

•    Coagulation Factor Concentrates

•    Other Plasma Fractionation Products

By End Users

•    Hospitals

•    Clinics

•    Research laboratories

•    Academic institutions

By Application

•    Immunology

•    Oncology

•    Pulmonology

•    Rheumatology

•    Transplantation

•    Neurology

•    Haematology

•    Other Applications

Blood Plasma Market Key Players

Some of the key participating players in blood plasma market are Adma Biologics Inc., Baxter International Inc., Cerus Corp., Octopharma Ag, and others

MMC Overview on Blood Plasma Market Report

The non-identical approach of Reports and Insights stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.

A research report on the Blood Plasma market by Reports and Insights is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that support market and the factors that are acting as impedance for the growth of the market.

Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth include (but not restricted to):

•    New product designs and launches

•    Current product compliance

•    Reimbursement

•    Concerns for use of Blood Plasma

•    Advantages of Blood Plasma over other modalities

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at the regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to make an informed decision.

A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.


To learn more about this report, request a free sample copy


1.    Global Blood Plasma Market Report Overview

1.1.    Introduction

1.2.    Report Description

1.3.    Methodology

2.    Global Blood Plasma Market Overview

2.1.    Introduction

2.1.1.    Introduction

2.1.2.    Market Taxonomy

2.2.    Executive Summary

2.3.    Global Blood Plasma Market Snapshot

2.4.    Global Blood Plasma Market Size and Forecast, 2020–2028

2.4.1.    Introduction

2.4.2.    Market Value Forecast and Annual Growth Rate (AGR) Comparison (2020–2028)

2.5.    Global Blood Plasma Market Dynamics

2.5.1.    Drivers

2.5.2.    Restraints

2.5.3.    Opportunity

2.5.4.    Trends

2.6.    Key Regulations

2.7.    Porter’s Five Forces Model

3.    Global Blood Plasma Market, By Blood Plasma Types

3.1.    Introduction

3.1.1.    Annual Growth Rate Comparison, By Blood Plasma Types

3.1.2.    BPS Analysis, By Blood Plasma Types

3.2.    Market Revenue (US$Mn) Forecast, By Blood Plasma Types

3.2.1.    Immunoglobulin

3.2.1.1.    Intravenous Immunoglobulin

3.2.1.2.    Subcutaneous Immunoglobulin

3.2.1.3.    Other Immunoglobulin Type

3.2.2.    Albumin

3.2.3.    Hyperimmune

3.2.4.    Coagulation Factor Concentrates

3.2.5.    Other Plasma Fractionation Products

3.3.    Global Blood Plasma Market Attractiveness Index, By Blood Plasma Types

4.    Global Blood Plasma Market, By End Users

4.1.    Introduction

4.1.1.    Annual Growth Rate Comparison, By End Users

4.1.2.    BPS Analysis, By End Users

4.2.    Market Revenue (US$Mn) Forecast, By End Users

4.2.1.    Hospitals

4.2.2.    Clinics

4.2.3.    Research laboratories

4.2.4.    Academic institutions

4.3.    Global Blood Plasma Market Attractiveness Index, By End Users

5.    Global Blood Plasma Market, By Application

5.1.    Introduction

5.1.1.    Annual Growth Rate Comparison, By Application

5.1.2.    BPS Analysis, By Application

5.2.    Market Revenue (US$Mn) Forecast, By Application

5.2.1.    Immunology

5.2.2.    Oncology

5.2.3.    Pulmonology

5.2.4.    Rheumatology

5.2.5.    Transplantation

5.2.6.    Neurology

5.2.7.    Haematology

5.2.8.    Other Applications

5.3.    Global Blood Plasma Market Attractiveness Index, By Application

6.    Global Blood Plasma Market, By Region

6.1.    Introduction

6.1.1.    Annual Growth Rate Comparison, By Region

6.1.2.    BPS Analysis, By Region

6.2.    Market Revenue (US$Mn) Forecast, By Region

6.2.1.    North America

6.2.2.    Latin America

6.2.3.    Europe

6.2.4.    Asia Pacific

6.2.5.    Middle East

6.2.6.    Africa

6.3.    Global Blood Plasma Market Attractiveness Index, By Region

7.    North America Blood Plasma Market Analysis and Forecast, 2020–2028

7.1.    Introduction

7.1.1.    Annual Growth Rate Comparison, By Country

7.1.2.    BPS Analysis, By Country

7.2.    Market Revenue (US$Mn) Forecast, By Country

7.2.1.    U.S. Blood Plasma Market

7.2.2.    Canada Blood Plasma Market

7.3.    North America Blood Plasma Market, By Blood Plasma Types

7.3.1.    Immunoglobulin

7.3.1.1.    Intravenous Immunoglobulin

7.3.1.2.    Subcutaneous Immunoglobulin

7.3.1.3.    Other Immunoglobulin Type

7.3.2.    Albumin

7.3.3.    Hyperimmune

7.3.4.    Coagulation Factor Concentrates

7.3.5.    Other Plasma Fractionation Products

7.4.    North America Blood Plasma Market, By End Users

7.4.1.    Hospitals

7.4.2.    Clinics

7.4.3.    Research laboratories

7.4.4.    Academic institutions

7.5.    North America Blood Plasma Market, By Application

7.5.1.    Immunology

7.5.2.    Oncology

7.5.3.    Pulmonology

7.5.4.    Rheumatology

7.5.5.    Transplantation

7.5.6.    Neurology

7.5.7.    Haematology

7.5.8.    Other Applications

7.6.    North America Blood Plasma Market Attractiveness Index

7.6.1.    By Country

7.6.2.    By Blood Plasma Types

7.6.3.    By End Users

7.6.4.    By Application

8.    Latin America Blood Plasma Market Analysis and Forecast, 2020–2028

8.1.    Introduction

8.1.1.    Annual Growth Rate Comparison, By Country

8.1.2.    BPS Analysis, By Country

8.2.    Market (US$Mn) Forecast, By Country

8.2.1.    Brazil Blood Plasma Market

8.2.2.    Mexico Blood Plasma Market

8.2.3.    Argentina Blood Plasma Market

8.2.4.    Rest of Latin America Blood Plasma Market

8.3.    Latin America Blood Plasma Market, By Blood Plasma Types

8.3.1.    Immunoglobulin

8.3.1.1.    Intravenous Immunoglobulin

8.3.1.2.    Subcutaneous Immunoglobulin

8.3.1.3.    Other Immunoglobulin Type

8.3.2.    Albumin

8.3.3.    Hyperimmune

8.3.4.    Coagulation Factor Concentrates

8.3.5.    Other Plasma Fractionation Products

8.4.    Latin America Blood Plasma Market, By End Users

8.4.1.    Hospitals

8.4.2.    Clinics

8.4.3.    Research laboratories

8.4.4.    Academic institutions

8.5.    Latin America Blood Plasma Market, By Application

8.5.1.    Immunology

8.5.2.    Oncology

8.5.3.    Pulmonology

8.5.4.    Rheumatology

8.5.5.    Transplantation

8.5.6.    Neurology

8.5.7.    Haematology

8.5.8.    Other Applications

8.6.    Latin America Blood Plasma Market Attractiveness Index

8.6.1.    By Country

8.6.2.    By Blood Plasma Types

8.6.3.    By End Users

8.6.4.    By Application

9.    Europe Blood Plasma Market Analysis and Forecast, 2020–2028

9.1.    Introduction

9.1.1.    Annual Growth Rate Comparison, By Country

9.1.2.    BPS Analysis, By Country

9.2.    Market (US$Mn) Forecast, By Country

9.2.1.    U.K. Blood Plasma Market

9.2.2.    Germany Blood Plasma Market

9.2.3.    Italy Blood Plasma Market

9.2.4.    France Blood Plasma Market

9.2.5.    Spain Blood Plasma Market

9.2.6.    Russia Blood Plasma Market

9.2.7.    Poland Blood Plasma Market

9.2.8.    BENELUX Blood Plasma Market

9.2.9.    NORDIC Blood Plasma Market

9.2.10.    Rest of Europe Blood Plasma Market

9.3.    Europe Blood Plasma Market, By Blood Plasma Types

9.3.1.    Immunoglobulin

9.3.1.1.    Intravenous Immunoglobulin

9.3.1.2.    Subcutaneous Immunoglobulin

9.3.1.3.    Other Immunoglobulin Type

9.3.2.    Albumin

9.3.3.    Hyperimmune

9.3.4.    Coagulation Factor Concentrates

9.3.5.    Other Plasma Fractionation Products

9.4.    Europe Blood Plasma Market, By End Users

9.4.1.    Hospitals

9.4.2.    Clinics

9.4.3.    Research laboratories

9.4.4.    Academic institutions

9.5.    North America Blood Plasma Market, By Application

9.5.1.    Immunology

9.5.2.    Oncology

9.5.3.    Pulmonology

9.5.4.    Rheumatology

9.5.5.    Transplantation

9.5.6.    Neurology

9.5.7.    Haematology

9.5.8.    Other Applications

9.6.    Europe Blood Plasma Market Attractiveness Index

9.6.1.    By Country

9.6.2.    By Blood Plasma Types

9.6.3.    By End Users

9.6.4.    By Application

10.    Asia Pacific Blood Plasma Market Analysis and Forecast, 2019–2027

10.1.    Introduction

10.1.1.    Annual Growth Rate Comparison, By Country

10.1.2.    BPS Analysis, By Country

10.2.    Market (US$Mn) Forecast, By Country

10.2.1.    China Blood Plasma Market

10.2.2.    India Blood Plasma Market

10.2.3.    Japan Blood Plasma Market

10.2.4.    Australia and New Zealand Blood Plasma Market

10.2.5.    South Korea Blood Plasma Market

10.2.6.    ASEAN Blood Plasma Market

10.2.7.    Rest of Asia Pacific Blood Plasma Market

10.3.    Asia Pacific Blood Plasma Market, By Blood Plasma Types

10.3.1.    Immunoglobulin

10.3.1.1.    Intravenous Immunoglobulin

10.3.1.2.    Subcutaneous Immunoglobulin

10.3.1.3.    Other Immunoglobulin Type

10.3.2.    Albumin

10.3.3.    Hyperimmune

10.3.4.    Coagulation Factor Concentrates

10.3.5.    Other Plasma Fractionation Products

10.4.    Asia Pacific Blood Plasma Market, By End Users

10.4.1.    Hospitals

10.4.2.    Clinics

10.4.3.    Research laboratories

10.4.4.    Academic institutions

10.5.    Asia Pacific Blood Plasma Market, By Application

10.5.1.    Immunology

10.5.2.    Oncology

10.5.3.    Pulmonology

10.5.4.    Rheumatology

10.5.5.    Transplantation

10.5.6.    Neurology

10.5.7.    Haematology

10.5.8.    Other Applications

10.6.    Asia Pacific Blood Plasma Market Attractiveness Index

10.6.1.    By Country

10.6.2.    By Blood Plasma Types

10.6.3.    By End Users

10.6.4.    By Application

11.    Middle East Blood Plasma Market Analysis and Forecast, 2019–2027

11.1.    Introduction

11.1.1.    Annual Growth Rate Comparison, By Country

11.1.2.    BPS Analysis, By Country

11.2.    Market (US$Mn) Forecast, By Country

11.2.1.    GCC Countries Blood Plasma Market

11.2.2.    Israel Blood Plasma Market

11.2.3.    Oman Blood Plasma Market

11.2.4.    Rest of Middle East Blood Plasma Market

11.3.    Middle East Blood Plasma Market, By Blood Plasma Types

11.3.1.    Immunoglobulin

11.3.1.1.    Intravenous Immunoglobulin

11.3.1.2.    Subcutaneous Immunoglobulin

11.3.1.3.    Other Immunoglobulin Type

11.3.2.    Albumin

11.3.3.    Hyperimmune

11.3.4.    Coagulation Factor Concentrates

11.3.5.    Other Plasma Fractionation Products

11.4.    Middle East Blood Plasma Market, By End Users

11.4.1.    Hospitals

11.4.2.    Clinics

11.4.3.    Research laboratories

11.4.4.    Academic institutions

11.5.    Middle East Blood Plasma Market, By Application

11.5.1.    Immunology

11.5.2.    Oncology

11.5.3.    Pulmonology

11.5.4.    Rheumatology

11.5.5.    Transplantation

11.5.6.    Neurology

11.5.7.    Haematology

11.5.8.    Other Applications

11.6.    Middle East Blood Plasma Market Attractiveness Index

11.6.1.    By Country

11.6.2.    By Blood Plasma Types

11.6.3.    By End Users

11.6.4.    By Application

12.    Africa Blood Plasma Market Analysis and Forecast, 2019–2027

12.1.    Introduction

12.1.1.    Annual Growth Rate Comparison, By Country

12.1.2.    BPS Analysis, By Country

12.2.    Market (US$Mn) Forecast, By Country

12.2.1.    South Africa Blood Plasma Market

12.2.2.    Egypt Blood Plasma Market

12.2.3.    North Africa Blood Plasma Market

12.2.4.    Rest of Africa Blood Plasma Market

12.3.    Africa Blood Plasma Market, By Blood Plasma Types

12.3.1.    Immunoglobulin

12.3.1.1.    Intravenous Immunoglobulin

12.3.1.2.    Subcutaneous Immunoglobulin

12.3.1.3.    Other Immunoglobulin Type

12.3.2.    Albumin

12.3.3.    Hyperimmune

12.3.4.    Coagulation Factor Concentrates

12.3.5.    Other Plasma Fractionation Products

12.4.    Africa Blood Plasma Market, By End Users

12.4.1.    Hospitals

12.4.2.    Clinics

12.4.3.    Research laboratories

12.4.4.    Academic institutions

12.5.    Africa Blood Plasma Market, By Application

12.5.1.    Immunology

12.5.2.    Oncology

12.5.3.    Pulmonology

12.5.4.    Rheumatology

12.5.5.    Transplantation

12.5.6.    Neurology

12.5.7.    Haematology

12.5.8.    Other Applications

12.6.    Africa Blood Plasma Market Attractiveness Index

12.6.1.    By Country

12.6.2.    By Blood Plasma Types

12.6.3.    By End Users

12.6.4.    By Application

13.    Recommendation

13.1.    Market Strategy

14.    Competitive Landscape

14.1.    Competition Dashboard

14.2.    List and Company Overview of Global Key Players

14.3.    Company Profiles

14.3.1.    Adma Biologics Inc.

14.3.1.1.    Company Overview

14.3.1.2.    Financial Overview

14.3.1.3.    Blood Plasma Types Portfolio

14.3.1.4.    Key Developments

14.3.1.5.    Business Strategies

14.3.2.    Baxter International Inc.

14.3.3.    Cerus Corp.

14.3.4.    General Electric Co.

14.3.5.    Octopharma Ag

14.3.6.    Others

15.    Acronyms

Select License Type

Frequently Asked Questions

The global blood plasma market in 2020 is estimated for more than US$ 21.1 Bn and expected to reach at a value of US$ 35.4 Bn by 2028 with a significant CAGR of 6.7%.

A huge upsurge in the count of patients suffering from hemophilia across the world, sluggish lifestyle of the population comprising unhealthy diets and no physical activity coupled with the growing geriatric population are the key factors driving the growth of market

The blood plasma market is segmented on the basis of blood plasma types, applications, end-user, and regions.

Some of the key participating players in blood plasma market are Adma Biologics Inc., Baxter International Inc., Cerus Corp., Octopharma Ag, and others